Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)
Modified by
  • Commission Implementing Regulation (EU) 2021/1008of 21 June 2021amending Annex I to Implementing Regulation (EU) 2021/620 as regards the disease-free status of Croatia and a region of Portugal from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations, amending Annex VIII thereto as regards the disease-free status of Lithuania and certain regions of Germany, Italy and Portugal from infection with bluetongue virus (serotypes 1-24) and amending Annex XIII thereto as regards the disease-free status of Denmark and Finland from infectious haematopoietic necrosis(Text with EEA relevance), 32021R1008, June 22, 2021
  • Commission Implementing Regulation (EU) 2021/1911of 27 October 2021amending Annex II to Implementing Regulation (EU) 2021/620 as regards the disease-free status of the Autonomous Community of Galicia and the Autonomous Community of Principado de Asturias in Spain from infection with Mycobacterium tuberculosis complex, amending Annex VIII thereto as regards the disease-free status of Autonomous Community of Islas Baleares, Huelva and Sevilla provinces and the regions of Azuaga, Badajoz, Mérida, Jerez de los Caballeros and Zafra in Badajoz province in Spain and Alentejo region and Santarém district in Lisboa e Vale do Tejo region in Portugal from infection with bluetongue virus, amending Annex IX thereto as regards the disease-free status of the Åland islands in Finland from infestation with Varroa spp and amending Annex XIII thereto as regards the disease-free status of Denmark and Finland regarding Infectious haematopoietic necrosis(Text with EEA relevance), 32021R1911, November 4, 2021
  • Commission Implementing Regulation (EU) 2022/214of 17 February 2022amending certain Annexes to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseases(Text with EEA relevance), 32022R0214, February 18, 2022
  • Commission Implementing Regulation (EU) 2022/1218of 14 July 2022amending certain Annexes to Implementing Regulation (EU) 2021/620 as regards the approval of the disease-free status of certain Member States or zones thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseases(Text with EEA relevance), 32022R1218, July 15, 2022
  • Commission Implementing Regulation (EU) 2023/150of 20 January 2023amending certain Annexes to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain Member States or zones or compartments thereof as regards certain listed diseases(Text with EEA relevance), 32023R0150, January 23, 2023
  • Commission Implementing Regulationz (EU) 2023/1071of 1 June 2023amending certain Annexes to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseases(Text with EEA relevance), 32023R1071, June 2, 2023
  • Commission Implementing Regulation (EU) 2023/2057of 26 September 2023amending Annexes VII and VIII to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain Member States or zones thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseases(Text with EEA relevance), 32023R2057, September 27, 2023
  • Commission Implementing Regulation (EU) 2023/2618of 23 November 2023amending certain Annexes to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain Member States or zones thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseases(Text with EEA relevance), 32023R2618, November 24, 2023
  • Commission Implementing Regulation (EU) 2024/566of 14 February 2024amending Annex VIII to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain zones of Germany and Spain as regards infection with bluetongue virus (serotypes 1-24) and the approval of the extension of an eradication programme for infection with that virus(Text with EEA relevance), 32024R0566, February 15, 2024
  • Commission Implementing Regulation (EU) 2024/1332of 17 May 2024amending certain Annexes to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseases(Text with EEA relevance), 32024R1332, May 21, 2024
  • Commission Implementing Regulation (EU) 2024/2032of 29 July 2024amending certain Annexes to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain Member States or zones thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseases(Text with EEA relevance), 32024R2032, July 30, 2024
Commission Implementing Regulation (EU) 2021/620of 15 April 2021laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases(Text with EEA relevance)
Article 1Subject matter and scope1.This Regulation lays down implementing rules for the listed diseases referred to in Article 9(1)(a), (b) and (c) of Regulation (EU) 2016/429 of animals, as regards the disease-free and non-vaccination status of certain Member StatesIn accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Regulation references to Member States include the United Kingdom in respect of Northern Ireland. or zones or compartments thereof, and the approval of eradication programmes for those listed diseases.2.The Annexes to this Regulation list both the Member States or zones or compartments thereof whose disease-free status or eradication programmes shall be deemed to be approved as provided for in Article 280 of Regulation (EU) 2016/429, and those whose disease-free status and eradication programmes shall be duly approved by this Regulation and also duly listed in the Annexes thereto.3.This Regulation lists in the Annexes thereto:(a)the Member States or zones or compartments thereof with approved compulsory eradication programmes for Category B diseases and optional eradication programmes for Category C diseases.(b)the Member States or zones thereof with approved disease-free status and non-vaccination status;(c)the compartments of Member States with recognised disease-free status.
Article 2Infection with Brucella abortus, B. melitensis and B. suis1.The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part I of Annex I.2.The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part I of Annex I.3.The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part II of Annex I.4.The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part II of Annex I.
Article 3Infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) (MTBC)1.The Member States or zones thereof with disease-free status from infection with Mycobacterium tuberculosis complex (Mycobacterium bovis, M.caprae and M. tuberculosis) (MTBC) shall be listed in Part I of Annex II.2.The Member States or zones thereof with an approved compulsory eradication programme for infection with MTBC shall be listed in Part II of Annex II.
Article 4Infection with rabies virus (RABV)1.The Member States or zones thereof with disease-free status from infection with rabies virus (RABV) shall be listed in Part I of Annex III.2.The Member States or zones thereof with an approved compulsory eradication programme for infection with RABV shall be listed in Part II of Annex III.
Article 5Enzootic bovine leukosis (EBL)1.The Member States or zones thereof with disease-free status from enzootic bovine leukosis (EBL) shall be listed in Part I of Annex IV.2.The Member States or zones thereof with an approved optional eradication programme for EBL shall be listed in Part II of Annex IV.
Article 6Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV)1.The Member States or zones thereof with disease-free status from infectious bovine rinotracheitis/infectious pustular vulvovaginitis (IBR/IPV) shall be listed in Part I of Annex V.2.The Member States or zones thereof with an approved optional eradication programme for IBR/IPV shall be listed in Part II of Annex V.
Article 7Infection with Aujeszky’s disease virus(ADV)1.The Member States or zones thereof with disease-free status from infection with Aujeszky’s disease virus (ADV) shall be listed in Part I of Annex VI.2.The Member States or zones thereof with an approved optional eradication programme for infection with ADV shall be listed in Part II of Annex VI.
Article 8Bovine viral diarrhoea (BVD)1.The Member States or zones thereof with disease-free status from Bovine viral diarroea (BVD) shall be listed in Part I of Annex VII.2.The Member States or zones thereof with an approved optional eradication programme for infection with BVD shall be listed in Part II of Annex VII.
Article 9Infection with bluetongue virus (serotypes 1-24) (infection with BTV)1.The Member States or zones thereof with disease-free status from infection with bluetongue virus (serotypes 1-24) (infection with BTV) shall be listed in Part I of Annex VIII.2.The Member States or zones thereof with an approved optional eradication programme for infection with BTV shall be listed in Part II of Annex VIII.
Article 10Infestation with Varroa spp.The Member States or zones thereof with disease-free status from infestation with Varroa spp. shall be listed in Annex IX.
Article 11Infection with Newcastle disease virusThe Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination shall be listed in Annex X.
Article 12Infection with highly pathogenic avian influenza (HPAI)Compartments of the Member States free from HPAI shall be listed in Annex XI.
Article 13Viral haemorrhagic septicaemia (VHS)1.The following shall be listed in Part I of Annex XII:(a)Member States where their whole territory has disease-free status from viral haemorrhagic septicaemia (VHS);(b)zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and(c)zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.2.The following shall be listed in Part II of Annex XII:(a)Member States where their whole territory has an approved eradication programme for VHS;(b)zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS; and(c)zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 14Infectious haematopoietic necrosis (IHN)1.The following shall be listed in Part I of Annex XIII:(a)Member States where their whole territory has disease-free status from infectious haematopoietic necrosis (IHN);(b)zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN; and(c)zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.2.The following shall be listed in Part II of Annex XIII:(a)Member States where their whole territory has an approved eradication programme for IHN;(b)zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and(c)zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 15Infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV)1.The following shall be listed in Part I of Annex XIV:(a)Member States where their whole territory has disease-free status from infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV);(b)zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and(c)zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.2.The following shall be listed in Part II of Annex XIV:(a)Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;(b)zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and(c)zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 16Infection with Marteilia refringens1.The following shall be listed in Part I of Annex XV:(a)Member States where their whole territory has disease-free status from infection with Marteilia refringens;(b)zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and(c)zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.2.The following shall be listed in Part II of Annex XV:(a)Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens;(b)zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and(c)zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 17Infection with Bonamia exitiosa1.The following shall be listed in Part I of Annex XVI:(a)Member States where their whole territory has disease-free status from infection with Bonamia exitiosa;(b)zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and(c)zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.2.The following shall be listed in Part II of Annex XVI:(a)Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa;(b)zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and(c)zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 18Infection with Bonamia ostreae1.The following shall be listed in Part I of Annex XVII:(a)Member States where their whole territory has disease-free status from infection with Bonamia ostreae;(b)zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and(c)zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.2.The following shall be listed in Part II of Annex XVII:(a)Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae;(b)zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and(c)zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 19Infection with white spot syndrome virus (WSSV)1.The following shall be listed in Part I of Annex XVIII:(a)Member States where their whole territory has disease-free status from infection with white spot syndrome virus (WSSV);(b)zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and(c)zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.2.The following shall be listed in Part II of Annex XVIII:(a)Member States where their whole territory has an approved eradication programme for infection with WSSV;(b)zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and(c)zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 20RepealThe following acts are repealed:Decision 93/52/EEC,Decision 94/963/EC,Decision 95/98/EC,Decision 2003/467/EC,Decision 2004/558/EC,Decision 2008/185/EC,Decision 2009/177/EC,Regulation (EC) No 616/2009,Implementing Decision 2013/503/EU.
Article 21Entry into force and applicationThis Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.It shall apply from 21 April 2021.
This Regulation shall be binding in its entirety and directly applicable in all Member States.ANNEX IINFECTION WITH BRUCELLA ABORTUS, B. MELITENSIS AND B. SUISPART IDisease-free status from infection with Brucella abortus, B. melitensis and B. suisCHAPTER 1Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
BelgiumWhole territory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory
EstoniaWhole territory
IrelandWhole territory
SpainWhole territory
FranceWhole territory
CroatiaWhole territory
ItalyRegione Abruzzo: Provincia di Pescara, TeramoRegione Basilicata: Provincia di MateraRegione Calabria: Provincia di Vibo ValentiaRegione Campania: Provincia di Avellino, Benevento, NapoliRegione Emilia-RomagnaRegione Friuli Venezia GiuliaRegione LazioRegione LiguriaRegione LombardiaRegione MarcheRegione Molise: Provincia di CampobassoRegione PiemonteRegione Puglia: Provincia di Bari, Barletta-Andria-Trani, Brindisi, LecceRegione Sicilia: Provincia de AgrigentoRegione SardegnaRegione ToscanaRegione Trentino – Alto AdigeRegione UmbriaRegione Valle d’AostaRegione Veneto
CyprusWhole territory
LatviaWhole territory
LithuaniaWhole territory
LuxembourgWhole territory
MaltaWhole territory
NetherlandsWhole territory
AustriaWhole territory
PolandWhole territory
PortugalDistritos Aveiro, Castelo Branco, Coimbra, Faro, Guarda, Leiria, Santarem, Setubal, ViseuRegião Autónoma dos Açores: Ilhas de Corvo, Faial, Flores, Graciosa, Pico, São Jorge, Santa Maria, Terceira
RomaniaWhole territory
SloveniaWhole territory
SlovakiaWhole territory
FinlandWhole territory
SwedenWhole territory
United Kingdom (Northern Ireland)Northern Ireland
CHAPTER 2Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
BelgiumWhole territory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory
EstoniaWhole territory
IrelandWhole territory
SpainWhole territory
FranceWhole territory
ItalyRegione AbruzzoRegione Basilicata: Provincia di MateraRegione Calabria: Province di Catanzaro, CosenzaRegione Campania: Province di Benevento, Napoli, SalernoRegione Emilia-RomagnaRegione Friuli Venezia GiuliaRegione LazioRegione LiguriaRegione LombardiaRegione MarcheRegione MoliseRegione PiemonteRegione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, TarantoRegione SardegnaRegione ToscanaRegione Trentino – Alto AdigeRegione UmbriaRegione Valle d’AostaRegione Veneto
CyprusWhole territory
LatviaWhole territory
LithuaniaWhole territory
LuxembourgWhole territory
HungaryWhole territory
NetherlandsWhole territory
AustriaWhole territory
PolandWhole territory
PortugalRegião Autónoma dos Açores
RomaniaWhole territory
SloveniaWhole territory
SlovakiaWhole territory
FinlandWhole territory
SwedenWhole territory
United Kingdom (Northern Ireland)Northern Ireland
PART IIMember States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suisCHAPTER 1Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in bovine animal populations
Member StateTerritory
BulgariaWhole territory
GreeceWhole territory
HungaryWhole territory
ItalyRegione Abruzzo: Provincia dell’Aquila, di ChietiRegione Basilicata: Provincia di PotenzaRegione Calabria: Provincia di Catanzaro, Cosenza, Crotone, Reggio CalabriaRegione Campania: Provincia di Caserta, SalernoRegione Molise: Provincia di IserniaRegione Puglia: Provincia di Foggia, TarantoRegione Sicilia except the Provincia of Agrigento
PortugalDistritos Beja, Braga, Braganca, Evora, Lisboa, Portalegre, Porto, Viana do Castelo, Vila RealRegião Autónoma da MadeiraRegião Autónoma dos Açores: Ilha de São Miguel
CHAPTER 2Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations
Member StateTerritory
BulgariaWhole territor
CroatiaWhole territory
GreeceWhole territory
ItalyRegione Basilicata: Provincia di PotenzaRegione Calabria: Province di Crotone, Reggio Calabria, Vibo ValentiaRegione Campania: Province d’Avellino, CasertaRegione Puglia: Provincia di FoggiaRegione Sicilia
PortugalRegião MadeiraDistritos Aveiro, Beja, Braga, Braganca, Castelo Branco, Coimbra, Evora, Faro, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu
ANNEX IIINFECTION WITH MYCOBACTERIUM TUBERCULOSIS COMPLEX (M. BOVIS, M. CAPRAE AND M. TUBERCULOSIS) (MTBC)PART IMember States or zones thereof with disease-free status from infection with MTBC
Member StateTerritory
BelgiumWhole territory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory
EstoniaWhole territory
SpainComunidad Autónoma de CanariasComunidad Autónoma de Castilla y León: Province of Burgos, León, ValladolidComunidad Autónoma de CataluñaComunidad Autónoma de GaliciaComunidad Autónoma de Islas BalearesComunidad Autónoma de MurciaComunidad Autónoma del País VascoComunidad Autónoma del Principado de Asturias
FranceWhole territory
ItalyRegione AbruzzoRegione Basilicata: Provincia di MateraRegione Calabria: Provincia di CatanzaroRegione Campania: Provincia di NapoliRegione Emilia-RomagnaRegione Friuli Venezia GiuliaRegione Lazio: Province di Frosinone, Latina, Rieti, ViterboRegione LiguriaRegione LombardiaRegione Marche: Province di Ancona, Ascoli Piceno, Fermo, Pesaro-UrbinoRegione MoliseRegione PiemonteRegione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, TarantoRegione SardegnaRegione ToscanaRegione Trentino – Alto AdigeRegione UmbriaRegione Valle d’AostaRegione Veneto
LatviaWhole territory
LithuaniaWhole territory
LuxembourgWhole territory
HungaryWhole territory
NetherlandsWhole territory
AustriaWhole territory
PolandWhole territory
PortugalRegião Algarve: all distritosRegião Autónoma dos Açores except Ilha de São Miguel
SloveniaWhole territory
SlovakiaWhole territory
FinlandWhole territory
SwedenWhole territory
PART IIMember States or zones thereof with an approved eradication programme for infection with MTBC
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
BulgariaWhole territory
CroatiaWhole territory
CyprusWhole territory
GreeceWhole territory
IrelandWhole territory
ItalyRegione Basilicata: Provincia di PotenzaRegione Calabria: Province di Cosenza, Crotone, Reggio Calabria, Vibo ValentiaRegione Campania: Province d’Avellino, Caserta, Benevento, SalernoRegione Lazio: Provincia di RomaRegione Marche: Provincia di MacerataRegione Puglia: Provincia di FoggiaRegione Sicilia
MaltaWhole territory
PortugalRegião Autónoma dos Açores: Ilha de São MiguelRegião Autónoma da MadeiraDistritos Aveiro, Beja, Braga, Bragança, Castelo Branco, Coimbra, Evora, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu
RomaniaWhole territory
SpainComunidad Autónoma de AndalucíaComunidad Autónoma de AragónComunidad Autónoma de CantabriaComunidad Autónoma de Castilla-La ManchaComunidad Autónoma de Castilla y León: Province of Ávila, Palencia, Salamanca, Segovia, Soria, ZamoraComunidad Autónoma de ExtremaduraComunidad Autónoma de La RiojaComunidad Autónoma de MadridComunidad Autónoma de NavarraComunidad Autónoma de Valencia
United Kingdom (Northern Ireland)Northern Ireland
ANNEX IIIINFECTION WITH THE RABIES VIRUS (RABV)PART IMember States or zones thereof with disease-free status from infection with RABV
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
BelgiumWhole territory
BulgariaWhole territory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory
EstoniaWhole territory
IrelandWhole territory
GreeceWhole territory
SpainWhole territory
FranceWhole territory
CroatiaWhole territory
ItalyWhole territory
CyprusWhole territory
LatviaWhole territory
LithuaniaWhole territory
LuxembourgWhole territory
HungaryWhole territory except Szabolcs-Szatmár-Bereg megye
MaltaWhole territory
NetherlandsWhole territory
AustriaWhole territory
PolandVoivodship Dolnośląskie: all powiatyVoivodship Kujawsko-pomorskie: all powiatyVoivodship Lubelskie the following powiaty: m. Lublin, Łęczyński, Parczewski, Radzyński, ŚwidnickiVoivodship Lubuskie: all powiatyVoivodship Łódzkie the following powiaty: Bełchatowski, Brzeziński, Kutnowski, Łaski, Łęczycki, Łowicki, Łódzki Wschodni, m. Łódź, Pabianicki, Pajęczański, Piotrkowski, m. Piotrków Trybunalski, Poddębicki, Radomszczański, Rawski, Sieradzki, Skierniewicki, m. Skierniewice, Tomaszowski, Wieluński, Wieruszowski, Zduńskowolski, ZgierskiVoivodship Małopolskie: all powiatyVoivodship Mazowieckie the following powiaty: Ciechanowski, Gostyniński, Makowski, Mławski, Ostrołęcki, m. Ostrołęka, Płocki, m. Płock, Przasnyski, Sierpecki, ŻuromińskiVoivodship Opolskie: all powiatyVoivodship Podlaskie: all powiatyVoivodship Pomorskie: all powiatyVoivodship Śląskie: all powiatyVoivodship Świętokrzyskie the following powiaty: Buski, Kazimierski, Pińczowski, WłoszczowskiVoivodship Warmińsko-mazurskie: all powiatyVoivodship Wielkopolskie: all powiatyVoivodship Zachodniopomorskie: all powiaty
PortugalWhole territory
SloveniaWhole territory
SlovakiaWhole territory, except the following regions:Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj PrešovskýMichalovce, Sobrance, Trebišov in kraj Košický
FinlandWhole territory
SwedenWhole territory
United Kingdom (Northern Ireland)Northern Ireland
PART IIMember States or zones thereof with an approved eradication programme for infection with RABV
Member StateTerritory
HungarySzabolcs-Szatmár-Bereg megye
PolandVoivodship Lubelskie the following powiaty: Bialski, m. Biała Podlaska, Biłgorajski, Chełmski, m. Chełm, Hrubieszowski, Janowski, Krasnostawski, Kraśnicki, Lubartowski, Lubelski, Łukowski, Opolski, Puławski, Rycki, Tomaszowski, Włodawski, Zamojski, m. ZamośćVoivodship Łódzkie the following powiaty: OpoczyńskiVoivodship Mazowieckie the following powiaty: Białobrzeski, Garwoliński, Grodziski, Grójecki, Kozienicki, Legionowski, Lipski, Łosicki, Miński, Nowodworski, Ostrowski, Otwocki, Piaseczyński, Płoński, Pruszkowski, Przysuski, Pułtuski, Radomski, m. Radom, Siedlecki, m. Siedlce, Sochaczewski, Sokołowski, Szydłowiecki, m.st. Warszawa, Warszawski Zachodni, Węgrowski, Wołomiński, Wyszkowski, Zwoleński, ŻyrardowskiVoivodship PodkarpackieVoivodship Świętokrzyskie the following powiaty: Jędrzejowski, Kielecki, m. Kielce, Konecki, Opatowski, Ostrowiecki, Sandomierski, Skarżyski, Starachowicki, Staszowski
RomaniaWhole territory
SlovakiaRegion Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj PrešovskýRegion Michalovce, Sobrance, Trebišov in kraj Košický
ANNEX IVENZOOTIC BOVINE LEUKOSIS (EBL)PART IMember States or zones thereof with disease-free status from EBL
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
BelgiumWhole territory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory
EstoniaWhole territory
IrelandWhole territory
SpainWhole territory
FranceRégion Auvergne et Rhône-AlpesRégion Bourgogne-Franche-ComtéRégion BretagneRégion Centre-Val de LoireRégion CorseRégion Grande EstRégion Hauts-de-FranceRégion Ile-de-FranceRégion NormandieRégion Nouvelle-AquitaineRégion OccitanieRégion Pays de la LoireRégion Provence-Alpes-Côte d’AzurRégion GuadeloupeRégion GuyaneRégion MartiniqueRégion Mayotte
ItalyWhole territory
CyprusWhole territory
LatviaWhole territory
LithuaniaWhole territory
LuxembourgWhole territory
NetherlandsWhole territory
AustriaWhole territory
PolandWhole territory
PortugalWhole territory, except Região Autónoma da Madeira
SloveniaWhole territory
SlovakiaWhole territory
FinlandWhole territory
SwedenWhole territory
United Kingdom (Northern Ireland)Northern Ireland
PART IIMember States or zones thereof with an approved eradication programme for EBL
Member StateTerritoryDate of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
CroatiaWhole territory18 July 2022
ANNEX VINFECTIOUS BOVINE RHINOTRACHEITIS/INFECTIOUS PUSTULAR VULVOVAGINITIS (IBR/IPV)PART IMember States or zones thereof with disease-free status from IBR/IPV
Member StateTerritory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory
ItalyRegione Valle d’AostaRegione Trentino – Alto Adige: Provincia Autonoma di Bolzano – Alto Adige
AustriaWhole territory
FinlandWhole territory
SwedenWhole territory
PART IIMember States or zones thereof with an approved eradication programme for IBR/IPV
Member StateTerritoryDate of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689
BelgiumWhole territory21 April 2021
FranceRégion Auvergne et Rhône-AlpesRégion Bourgogne-Franche-ComtéRégion BretagneRégion Centre-Val de LoireRégion Grande EstRégion Hauts-de-FranceRégion Ile-de-FranceRégion NormandieRégion Nouvelle-AquitaineRégion OccitanieRégion Pays de la LoireRégion Provence-Alpes-Côte d’Azur21 April 2021
ItalyRegion Friuli Venezia GiuliaRegione Trentino – Alto Adige: Provincia Autonoma di Trento21 April 2021
LuxembourgWhole territory21 April 2021
SlovakiaKraj BratislavaKraj KošiceKraj PrešovKraj TrnavaKraj Žilina5 June 2023
ANNEX VIAUJESZKY’S DISEASE VIRUS (ADV)PART IMember States or zones thereof with disease-free status from infection with ADV
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
BelgiumWhole territory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory
EstoniaWhole territory
IrelandWhole territory
FranceThe departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Côtes-d’Armor, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Finistère, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Ille-et-Vilaine, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Morbihan, Moselle, Nièvre, Nord, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines
ItalyRegione Friuli Venezia GiuliaRegione Trentino – Alto AdigeRegione Veneto
CyprusWhole territory
LuxembourgWhole territory
HungaryWhole territory
NetherlandsWhole territory
AustriaWhole territory
PolandWhole territory
PortugalRegião Autónoma dos Açores
SloveniaWhole territory
SlovakiaWhole territory
FinlandWhole territory
SwedenWhole territory
United Kingdom (Northern Ireland)Northern Ireland
PART IIMember States or zones thereof with an approved eradication programme for infection with ADV
Member StateTerritoryDate of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689
SpainWhole territory21 April 2021
ItalyRegione AbruzzoRegione ApuliaRegione BasilicataRegione CalabriaRegione CampaniaRegione Emilia-RomagnaRegione LazioRegione LiguriaRegione LombardiaRegione MarcheRegione MoliseRegione PiemonteRegione SiciliaRegione ToscanaRegione Valle d’AostaRegione Umbria21 April 2021
LithuaniaWhole territory21 April 2021
PolandVoivodship Dolnośląskie: all powiatyVoivodship Kujawsko-Pomorskie: all powiatyVoivodship Lubelskie: all powiatyVoidodship Lubuskie: all powiatyVoivodship Lódzkie: all powiatyVoivodship Małopolskie: all powiatyVoivodship Mazowieckie: all powiatyVoivodship Opolskie: all powiatyVoivodship Podkarpackie: all powiatyVoivodship Podlaskie the following powiaty: Grajewski, Kolneński, Łomżyński, Łomża, Wysokomazowiecki, ZambrowskiVoivodship Pomorskie: all powiatyVoivodship Sląskie: all powiatyVoivodship Swiętokrzyskie: all powiatyVoivodship Warmińsko-mazurskie: all powiatyVoivodship Wielkopolskie: all powiatyVoivodship Zachodniopomorskie: all powiaty21 April 2021
PortugalWhole peninsular territory21 April 2021
ANNEX VIIBOVINE VIRAL DIARRHOEA (BVD)PART IMember States or zones thereof with disease-free status from BVD
Member StateTerritory
AustriaWhole territory
DenmarkWhole territory
FinlandWhole territory
GermanyBundesland Baden-WürttembergBundesland BayernBundesland BrandenburgBundesland BremenBundesland HamburgBundesland HessenBundesland Mecklenburg-VorpommernBundesland Niedersachsen, except Landkreis CuxhavenBundesland Nordrhein-Westfalen, except Kreis Borken, Gütersloh, Höxter, PaderbornBundesland Schleswig-HolsteinBundesland Rheinland-PfalzBundesland SaarlandBundesland SachsenBundesland Sachsen-AnhaltBundesland Thüringen
SwedenWhole territory
PART IIMember States or zones thereof with an approved eradication programme for BVD
Member StateTerritoryDate of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
GermanyBundesland BerlinBundesland Niedersachsen: Landkreis CuxhavenBundesland Nordrhein-Westfalen: Kreis Borken, Gütersloh, Höxter, Paderborn21.2.2022
IrelandWhole territory18 July 2022
ANNEX VIIIINFECTION WITH BLUETONGUE VIRUS (BTV)PART IMember States or zones thereof with disease-free status from infection with BTV
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
BelgiumWhole territory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory except Bundesland Bremen, Hessen, Niedersachsen, Nordrhein-Westfalen, Rheinland-Pfalz
EstoniaWhole territory
IrelandWhole territory
SpainComunidad Autónoma de AragónComunidad Autónoma de CanariasComunidad Autónoma de Castilla-La Mancha: Provincia of GuadalajaraComunidad Autónoma de Castilla y León, except the following areas:Provincia of ÁvilaProvincia of SalamancaCantalejo, Carbonero El Mayor, Santa María la Real de Nieva, Segovia, Villacastín in the Provincia of SegoviaAlcañices, Bermillo de Sayago, Puebla de Sanabria in the provincia of ZamoraComunidad Autónoma de La RiojaComunidad Autónoma de las Islas BalearesComunidad Autónoma de NavarraComunidad Autónoma del País VascoComunidad Autónoma de Valencia: provincia of Castellón and provincia of Valencia
ItalyProvincia Autonoma di Bolzano – Alto AdigeRegione Valle d’AostaRegione Friuli Venezia Giulia
LatviaWhole territory
LithuaniaWhole territory
LuxembourgWhole territory
HungaryWhole territory
NetherlandsWhole territory
AustriaWhole territory
PolandWhole territory
PortugalRegião Autónoma dos AçoresRegião Autónoma da Madeira
SloveniaWhole territory
SlovakiaWhole territory
FinlandWhole territory
SwedenWhole territory
United Kingdom (Northern Ireland)Northern Ireland
PART IIMember States or zones thereof with an approved eradication programme for infection with BTV
Member StateTerritoryDate of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
SpainComunidad Autónoma de AndalucíaComunidad Autónoma de Castilla-La Mancha, except the provincia of GuadalajaraComunidad Autónoma de AsturiasComunidad Autónoma de CantabriaComunidad Autónoma de Castilla y León:provincia of ÁvilaProvincia of SalamancaCantalejo, Carbonero El Mayor, Santa María la Real de Nieva, Segovia, Villacastín in the provincia of SegoviaAlcañices, Bermillo de Sayago, Puebla de Sanabria in the provincia of ZamoraComunidad Autónoma de CataluñaComunidad Autónoma de ExtremaduraComunidad Autónoma de GaliciaComunidad Autónoma de MadridComunidad Autónoma de MurciaComunidad Autónoma de Valencia: provincia of Alicante.21.2.2022
ANNEX IXINFESTATION WITH VARROA SPP.Member States or zones thereof with disease-free status from infestation with Varroa spp.
Member StateTerritory
PortugalIsland of CorvoIsland of GraciosaIsland of São JorgeIsland of Santa MariaIsland of São MiguelIsland of Terceira
FinlandÅland Islands, except the municipality of Brändö
ANNEX XINFECTION WITH NEWCASTLE DISEASE VIRUSMember States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination
Member StateTerritory
FinlandWhole territory
SwedenWhole territory
ANNEX XIHIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI)Compartments free from HPAI
Member StateName
FranceCompartiment ISA Bretagne comprising the establishments with codes EDE 22080055, 22277180, 22203429, 22059174 and 22295000.Compartiment SASSO Sabres comprising the establishment with Code EDE 40246082.Compartiment SASSO Soulitré comprising the establishment with Code EDE 72341105.
NetherlandsVerbeek’s poultry international B.V with approval number 1122.Institut de selection animale B.V with approval number 2338.Cobb Europe B.V. with approval number 2951.
ANNEX XIIVIRAL HAEMORRHAGIC SEPTICAEMIA (VHS)PART IMember States whose whole territory has disease-free status from VHS;zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; andzones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
DenmarkWhole territory
EstoniaWhole territory
IrelandWhole territory
CyprusWhole continental territory
FinlandWhole territory
SwedenWhole territory
United Kingdom (Northern Ireland)Northern Ireland
PART IIMember States where their whole territory has an approved eradication programme for VHS;zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS;and zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member StateTerritoryDate of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689
EstoniaWhole territory21 April 2021
ANNEX XIIIINFECTIOUS HAEMATOPOIETIC NECROSIS (IHN)PART IMember States where their whole territory has disease-free status from IHN;zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN;and zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
DenmarkWhole territory, except the area around Hove Kalkgrav up to a distance of 1 km from the centre of the lakes and the water catchment areas of Rohden Å, Sneum Å, Vidå, Lindenborg Å, Århus Å, Varde Å, Kolding Å
EstoniaWhole territory
IrelandWhole territory
CyprusWhole continental territory
FinlandWhole territory except the coastal compartment comprised of the parts of Eckerö and Hammarland municipalities that are contained within a 10 km radiuscircle, centered on WGS84 coordinates Lat 60,207175390°, Lon 19,507907780°
SwedenWhole territory
United Kingdom (Northern Ireland)Northern Ireland
PART IIMember States where their whole territory has an approved eradication programme for IHN;zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; andzones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member StateTerritoryDate of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689
EstoniaWhole territory21 April 2021
ANNEX XIVINFECTION WITH HIGHLY POLYMORPHIC REGION DELETED INFECTIOUS SALMON ANAEMIA VIRUS (HPR-DELETED ISAV)PART IMember States where their whole territory has disease-free status from infection with HPR-deleted ISAV;zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; andzones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
BelgiumWhole territory
BulgariaWhole territory
CzechiaWhole territory
DenmarkWhole territory
GermanyWhole territory
EstoniaWhole territory
IrelandWhole territory
GreeceWhole territory
SpainWhole territory
FranceWhole territory
CroatiaWhole territory
ItalyWhole territory
CyprusWhole territory
LatviaWhole territory
LithuaniaWhole territory
LuxembourgWhole territory
HungaryWhole territory
MaltaWhole territory
NetherlandsWhole territory
AustriaWhole territory
PolandWhole territory
PortugalWhole territory
RomaniaWhole territory
SloveniaWhole territory
SlovakiaWhole territory
FinlandWhole territory
SwedenWhole territory
United Kingdom (Northern Ireland)Northern Ireland
PART IIMember States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; andzones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third countryNone at present.ANNEX XVINFECTION WITH MARTEILIA REFRINGENSPART IMember States where their whole territory has disease-free status from infection with Marteilia refringens;zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; andzones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
IrelandWhole territory
United Kingdom (Northern Ireland)The whole coastline of Northern Ireland, except for Belfast Lough and Dundrum Bay.
PART IIMember States where their whole territory has an approved eradication programme for infection with Marteilia refringens;zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; andzones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third countryNone at present.ANNEX XVIINFECTION WITH BONAMIA EXITIOSAPART IMember States where their whole territory has disease-free status from infection with Bonamia exitiosa;zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; andzones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member StateTerritory
EstoniaWhole territory
PART IIMember States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa;zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; andzones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third countryNone at present.ANNEX XVIIINFECTION WITH BONAMIA OSTREAEPART IMember States where their whole territory has disease-free status from infection with Bonamia ostreae;zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; andzones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
Member StateTerritory
EstoniaWhole territory
IrelandThe whole coastline of Ireland, except: Cork Harbour; Galway Bay; Ballinakill Harbour; Clew Bay; Achill Sound; Loughmore, Blacksod Bay; Lough Foyle; Lough Swilly; and Kilkieran Bay.
United Kingdom (Northern Ireland)The whole coastline of Northern Ireland, except: Lough Foyle and Strangford Lough.
PART IIMember States where their whole territory has an approved eradication programme for infection with Bonamia ostreae;zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; andzones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third countryNone at present.ANNEX XVIIIINFECTION WITH WHITE SPOT SYNDROME VIRUS (WSSV)PART IMember States where their whole territory has disease-free status from infection with WSSV;zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; andzones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third countryNone at present.PART IIMember States where their whole territory has an approved eradication programme for infection with WSSV;zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; andzones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third countryNone at present.
Loading ...